We are live on ! Find out more
CTMX icon

CytomX Therapeutics
CTMX

62 hedge funds and large institutions have $308M invested in CytomX Therapeutics in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

60% more capital invested

Capital invested by funds: $193M → $308M (+$116M)

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

3% more funds holding

Funds holding: 60 → 62 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
62
Holders Change
+2
Holders Change %
+3.33%
% of All Funds
1.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
22
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$12.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$5M
3
Northern Trust
Northern Trust
Illinois
+$1.41M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.27M
5
CS
Candriam SCA
Luxembourg
+$1.06M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$7.58M
2
BA
BlackRock Advisors
Delaware
-$2.53M
3
CC
Casdin Capital
New York
-$1.29M
4
EA
Emerald Acquisition
Washington
-$264K
5
RG
Redmile Group
California
-$232K
Name Holding Trade Value Shares
Change 		Change in
Stake
ROTUOC
26
Regents of the University of California
California
$1.12M – – –
Bank of America
27
Bank of America
North Carolina
$1.12M +$825K +68,165 +2,158%
Charles Schwab
28
Charles Schwab
California
$1.12M +$356K +29,444 +71%
VIA
29
Vident Investment Advisory
Georgia
$1.06M -$3.93K -325 -0.5%
VM
30
VHCP Management
New York
$1.01M – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$676K +$3.63K +300 +0.7%
TA
32
Teachers Advisors
New York
$514K – – –
SIM
33
Spark Investment Management
New York
$374K +$289K +23,904 New
Swiss National Bank
34
Swiss National Bank
Switzerland
$353K – – –
EA
35
Emerald Acquisition
Washington
$342K -$264K -21,842 -50%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$328K – – –
CS
37
Credit Suisse
Switzerland
$286K +$53.1K +4,388 +32%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$270K +$27.8K +2,300 +15%
MLICM
39
Metropolitan Life Insurance Company (MetLife)
New York
$269K – – –
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$242K -$3.65K -302 -2%
Neuberger Berman Group
41
Neuberger Berman Group
New York
$224K +$173K +14,300 New
VKH
42
Virtu KCG Holdings
New York
$211K +$163K +13,454 New
NFA
43
Nationwide Fund Advisors
Ohio
$203K – – –
AIG
44
American International Group
New York
$185K +$218 +18 +0.2%
BlackRock
45
BlackRock
New York
$146K +$21.3K +1,759 +23%
Wells Fargo
46
Wells Fargo
California
$122K +$67.8K +5,600 +254%
SG Americas Securities
47
SG Americas Securities
New York
$117K +$90.5K +7,478 New
Morgan Stanley
48
Morgan Stanley
New York
$75K +$43.2K +3,574 +308%
Legal & General Group
49
Legal & General Group
United Kingdom
$58K – – –
Deutsche Bank
50
Deutsche Bank
Germany
$52K +$2.77K +229 +7%
1
2
3

CTMX Hedge Fund Activity: Q3 2016 in Review

62 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in CytomX Therapeutics (CTMX) for Q3 2016, worth a combined $308M — up 60% from $193M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CTMX positions and 5 closed out — a net gain of 2 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was Putnam Investments, adding an estimated $12.6M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $7.58M sold.

  • 62 institutional investors held CytomX Therapeutics (CTMX) as of Q3 2016, up from 60 in Q2 2016.
  • Funds reported $308M of CytomX Therapeutics stock for Q3 2016, up 60% quarter-over-quarter.
  • 7 funds opened new CytomX Therapeutics positions in Q3 2016 and 5 closed out, a net change of +2 holders.
  • The largest CytomX Therapeutics buyer in Q3 2016 was Putnam Investments, an estimated $12.6M added.
  • The largest CytomX Therapeutics seller in Q3 2016 was Perceptive Advisors, an estimated $7.58M sold.

Based on aggregated 13F filings for Q3 2016.